January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
9 Fast Fact about Avian Influenza for Primary Care
The bird flu threat remains low, according to public health authorities, but awareness and vigilance will help keep it that way. Here are 9 things you need to know.
A Vaccination Imperative: "Please, Let's Do It," NFID Medical Director Robert Hopkins, Jr, MD, Urges
The National Foundation for Infectious Diseases medical director appeals to the community at large to set politics and personal grievance aside and to "first, do no harm."
Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose
Pandemic Medical Misinformation Has Not Prompted Disciplinary Action: Daily Dose
CDC Releases Annual STI Report: Daily Dose
USPSTF Reaffirms Syphilis Screening for Pregnant Individuals Amid Rising Congenital Syphilis Rates
Comments on the draft recommendation can be submitted through December 23, 2024.
Online Misinformation on UTIs, ASB is Common and Dangerous: New Research
At least 1 accurate UTI symptom was found on most of the 331 websites reviewed, but nearly all (80%) included at least 1 inaccurate or misleading one.
New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research
The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.
Antivirals for Influenza Underutilized Among Vulnerable Children, Adolescents
Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.
STI Epidemic in US Shows Signs of Slowing, According to New CDC Report
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November Issue of Patient Care Online Digital Edition is Now Live
Find details on the surge in US pertussis cases, the first self-administered flu vaccine, and study findings underscoring the evolving nature of long COVID.
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals
CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.
The Legacy of Vaccine Hesitancy: From COVID-19 to Flu
Vaccine hesitancy became a public health threat during the COVID-19 pandemic that lingers now and has affected uptake of other essential immunizations.
Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults
IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.
IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines
IDWeek2024: The nanoparticle influenza vaccine and combination flu-Covid-19 shot produced immunogenicity comparable to or higher than comparator vaccines.
New Data Highlight Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake
IDWeek 2024: Black individuals were less likely to be vaccinated against all 3 respiratory viruses than White individuals, according to new research.
Pertussis Cases Increasing in US: Daily Dose
Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.
FDA Grants Marketing Authorization to First OTC Flu/COVID-19 Test Outside Emergency Use Declaration
The non-prescription test has more than 95% sensitivity and specificity for SARS-COV-2 and influenza A and B and delivers results in approximately 15 minutes.
Flu Vaccine Reduced Related Hospitalizations by About One-Third in Southern Hemisphere, but Uptake Still Low
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
US Pertussis Cases Increase Nearly 5-Fold During 2024, According to the CDC
The surge in pertussis is likely a result of a return to pre-pandemic infection patterns coupled with waning immunity from previous vaccination, CDC says.
RSV Mortality Higher than for Influenza B 90 Days After Hospital Discharge: New Data
Older adults hospitalized with RSV were older, more frail, and more likely to have respiratory comorbidities than those with influenza A or B, the study found.
FDA Approves First Self-Administered Flu Vaccine: Daily Dose
7 Drugs Approved for Primary Care: Q3 2024
Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.
High Percentage of Patients Seek Mental Health Care from PCPs, According to New Large Analysis
One in 9 primary care encounters involved a mental health condition, according to an analysis of over 350 million primary care visits.
First Self-Administered Flu Vaccine Approved by US FDA
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.